Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Roche”
Sponsor: Hoffmann-La Roche
Neovascular Age-related Macular Degeneration · nAMD
China
Sponsor: Hoffmann-La Roche
Moderately to Severely Active Crohns Disease
United States, Argentina, Australia, Austria, Belgium +21 more
Sponsor: Hoffmann-La Roche
Spinal Muscle Atrophy
Egypt
Sponsor: Hoffmann-La Roche
Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma
United States, Australia, Israel, South Korea, Spain +2 more
- A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Myelin Oligodendrocyte Glycoprotein Antibody-associated DiseaseActive Not Recruiting
Sponsor: Hoffmann-La Roche
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)
United States, Australia, Brazil, Canada, France +6 more
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RG6496 in Huntington's DiseaseActive Not Recruiting
Sponsor: Hoffmann-La Roche
Huntington's Disease
Argentina, Australia, Canada, New Zealand, United Kingdom
Sponsor: Hoffmann-La Roche
Urothelial Carcinoma · Bladder Cancer
United States, France, Greece, South Korea, Spain +2 more
- A Study Investigating the Safety of RO7795081 and How the Body Processes RO7795081 in People With Normal or Decreased Kidney FunctionsNot Yet Recruiting
Sponsor: Hoffmann-La Roche
Renal Impairment
Sponsor: Hoffmann-La Roche
Choroidal Neovascularization Secondary to Pathologic Myopia
Australia, China, France, Germany, Hong Kong +6 more
Sponsor: Hoffmann-La Roche
Neovascular Age-Related Macular Degeneration
United States, Argentina, Australia, Austria, Belgium +10 more
- A Study to Determine the Efficacy, Safety, and Durability of Faricimab in Participants With Neovascular Age-Related Macular DegenerationActive Not Recruiting
Sponsor: Hoffmann-La Roche
Neovascular Age-related Macular Degeneration (nAMD)
United States, Australia, Canada, China, France +7 more
Sponsor: Hoffmann-La Roche
Thyroid Eye Disease · TED
United States, Argentina, Australia, Austria, Germany +5 more
Sponsor: Hoffmann-La Roche
Neovascular Age-related Macular Degeneration (nAMD)
Argentina, Australia, Austria, Belgium, Brazil +11 more
- A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)Active Not Recruiting
Sponsor: Hoffmann-La Roche
Multiple Sclerosis
United States, Argentina, Australia, Belgium, Brazil +16 more
Sponsor: Neuron23 Inc.
Parkinson Disease · Parkinson · Idiopathic Parkinson Disease · Early Parkinson Disease (Early PD)
United States, Israel, Italy, Poland, Spain +1 more
Sponsor: University of Southern California
Gastric Cancer · Esophageal Cancer
United States
- A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple SclerosisActive Not Recruiting
Sponsor: Hoffmann-La Roche
Multiple Sclerosis
United States, Argentina, Australia, Austria, Belarus +32 more
- ABC-lung: Atezolizumab, Bevacizumab and Chemotherapy in EGFR-mutant Non-small Cell Lung CarcinomaCompleted
Sponsor: ETOP IBCSG Partners Foundation
EGFRmutant Stage IIIB/C or IV Non-squamous NSCLC
Germany, Singapore, South Korea, Spain, Switzerland
- Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]Active Not Recruiting
Sponsor: Hoffmann-La Roche
Non-Small Cell Lung Cancer
United States, Australia, Belgium, China, France +16 more
Sponsor: Hoffmann-La Roche
Non-Hodgkin's Lymphoma
United States, Australia, Belgium, Canada, Czechia +8 more
- A Study of TACE Combined With Atezolizumab Plus Bevacizumab or TACE Alone in Patients With Untreated Heaptocellular CarcionmaActive Not Recruiting
Sponsor: Hoffmann-La Roche
Hepatocellular Carcinoma
China, Japan
Sponsor: Hoffmann-La Roche
Alzheimer's Disease
Canada, Netherlands, Spain, Sweden, United Kingdom
Sponsor: Hoffmann-La Roche
Type 1 Diabetes Mellitus · Type 2 Diabetes Mellitus
Poland, Turkey (Türkiye)
- Frequency of Selected Single Nucleotide Polymorphisms in Huntington Disease Gene Expansion CarriersCompleted
Sponsor: Hoffmann-La Roche
Huntington Disease
United States, Argentina, Australia, Canada, Denmark +7 more
- A Study of Atezolizumab With or Without Tiragolumab Following Neoadjuvant Chemoradiotherapy in Participants With Locally Advanced Rectal CancerActive Not Recruiting
Sponsor: Hoffmann-La Roche
Rectal Neoplasms · Rectal Cancer
China